Endovia Health Sciences (EDVA) Capital Expenditures (2014 - 2024)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Capital Expenditures (2014 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1,735.00 |
| Jun 30, 2024 | 1,500.00 |
| Dec 31, 2023 | 1,500.00 |
| Jun 30, 2023 | 2,042.00 |
| Mar 31, 2023 | 10,571.00 |
| Dec 31, 2022 | 57,278.00 |
| Sep 30, 2022 | 45,420.00 |
| Dec 31, 2020 | 81,373.00 |
| Sep 30, 2020 | 4,254.00 |
| Jun 30, 2020 | 3,020.00 |
| Mar 31, 2020 | 2,419.00 |
| Dec 31, 2019 | 2,610.00 |
| Sep 30, 2019 | 5,416.00 |
| Jun 30, 2019 | -2,838.00 |
| Mar 31, 2019 | 7,364.00 |
| Dec 31, 2018 | 30,744.00 |
| Sep 30, 2018 | 19,531.00 |
| Jun 30, 2018 | 12,606.00 |
| Mar 31, 2018 | 12,752.00 |
| Dec 31, 2017 | 10,076.00 |